We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current SKYE market cap is 218.09M. The company's latest EPS is USD -1.3412 and P/E is -9.55.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 152k | 0 | 0 | 0 |
Operating Income | -3.1M | -2.84M | -24.71M | -4.09M | -6.15M |
Net Income | -5.17M | -3.11M | -24.95M | -4.42M | -5.02M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 152k |
Operating Income | -6.63M | -6.29M | -7.85M | -18.31M | -34.74M |
Net Income | 1.05M | -6.56M | -8.52M | -19.48M | -37.65M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 4.59M | 2.24M | 15.6M | 11.94M | 94.84M |
Total Liabilities | 9.37M | 10.03M | 13.91M | 14.07M | 15.95M |
Total Equity | -4.78M | -7.79M | 1.7M | -2.13M | 78.88M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 2M | 2.67M | 9.86M | 9.11M | 11.94M |
Total Liabilities | 1.45M | 2.22M | 3.99M | 12.12M | 14.07M |
Total Equity | 548k | 451k | 5.86M | -3.01M | -2.13M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -4.06M | -6.05M | -10.11M | -13.95M | -4.71M |
Investing | 5.53M | 5.53M | 6.6M | 6.6M | 1.14M |
Financing | -45k | -169k | 16.47M | 16.44M | 85.65M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -6.03M | -6.06M | -6.47M | -12.74M | -13.95M |
Investing | N/A | -7k | -91k | 5.21M | 6.6M |
Financing | 6.01M | 6.7M | 13.08M | -209k | 16.44M |
Market Cap | 218.09M |
Price to Earnings Ratio | -9.55 |
Price to Sales Ratio | 2.37k |
Price to Cash Ratio | 285.94 |
Price to Book Ratio | -168.64 |
Dividend Yield | - |
Shares Outstanding | 28.07M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 4.64 (59.79%) |
Company Name | Skye Bioscience Inc |
Address |
701 s carson st carson city, nevada 89701 |
Website | https://skyebioscience.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions